ArticleJournal of thoracic disease2025
Robotic-assisted thymectomy for locally advanced thymic malignancy: technical refinement and oncologic outcomes from a 20-year cohort.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Nodal dissection in thymic surgery: a narrative review of the evolution of practice and evidence in the era of the 9th edition TNM classification (2000-2025).Mediastinum (Hong Kong, China) · 2026Review
- Optimising individualised treatment decisions for locally advanced thymoma: precision selection of minimally invasive surgery and postoperative adjuvant radiotherapy.Frontiers in oncology · 2026Review
- Evolving paradigms in thymoma surgery and multidisciplinary care: a narrative review.Mediastinum (Hong Kong, China) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Robotic-assisted thymectomy (r-ThX) is commonly performed for early-stage thymic malignancies, but its use in advanced-stage disease has not been well studied. This study evaluated the safety and oncological outcomes of r-ThX in patients diagnosed with locally advanced thymic malignancies, particularly those with partial invasion of major vessels, pericardium, pleura, or phrenic nerve. Methods: In a single-center cohort study from January 2003 to January 2024, 41 consecutive patients with tumor-node-metastasis (TNM) stage II-IV thymic malignancies underwent thymectomy (r-ThX: 20, sternotomy: 21). We assessed the technical feasibility and clinical outcomes of r-ThX and proposed a decision algorithm describing patient selection of r-ThX and criteria of conversion to open surgery. Results: Patients in the sternotomy group had more advanced disease compared to those in the r-ThX group in terms of tumor size (8.0 Conclusions: r-ThX is a viable alternative to sternotomy for selected patients with locally advanced thymic malignancies with partial invasions. Conversion to open surgery is crucial for major vessel involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.